Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01464164 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia
A Phase 1 study, sponsored by Northwell Health.
- Terminated
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT01464164 is a Phase 1 study that was terminated before completion, run by Northwell Health. The registered enrollment target is 19 participants.
The verdict
NCT01464164, a Phase 1 study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and dosing of drug Sotatercept, as a subcutaneous injection, to stimulate production of red blood cell production. To be given every 28 days for up to four doses.
Interventions
- DRUG Sotatercept
- DRUG Sotatercept with prednisone boost
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-01 |
| Est. Completion | 2021-04-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01464164
The ClinicalTrials.gov registry entry for NCT01464164 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sotatercept is the first listed.
NCT01464164 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01464164 about?
NCT01464164 is a clinical study titled "Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia". The purpose of this study is to determine the safety and dosing of drug Sotatercept, as a subcutaneous injection, to stimulate production of red blood cell production. To be given every 28 days for up to four doses.
What is the current status of trial NCT01464164?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2012-01. Estimated completion is 2021-04-13.
What interventions are being tested in trial NCT01464164?
The interventions under investigation include: Sotatercept (DRUG), Sotatercept with prednisone boost (DRUG).
Who is sponsoring clinical trial NCT01464164?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.